The Likud's primary election, by contrast, will enable the entire rank-and-file to choose between Mr Netanyahu and the incumbent party leader, Ariel Sharon.

ECONOMIST: Can Bibi foil Barak��s bid to block him?

Matt Herper: Speeding forward a decade: Why did you decide to file for approval, FDA approval, that first time, given that the studies had missed their primary endpoints and that a third study, the IMPACT trial, was already going on?

FORBES: The Man Behind The First Cancer-Treating Vaccine On The FDA And Innovation